Azathioprine and UVA light generate mutagenic oxidative DNA damage
about
Posttransplantation malignancy in a patient presenting with weight loss and changed bowel habits: a case reportProtein oxidation, UVA and human DNA repairInflammatory bowel disease and cancer: The role of inflammation, immunosuppression, and cancer treatmentIncidence, risk factors and outcomes of de novo malignancies post liver transplantationUse of biologics and chemotherapy in patients with inflammatory bowel diseases and cancerClinical features, pathogenesis, and treatment of myasthenia gravis: a supplement to the Guidelines of the German Neurological SocietyReview article: dermatological complications of immunosuppressive and anti-TNF therapy in inflammatory bowel diseaseSkin cancer in organ transplant recipients: effects of immunosuppressive medications on DNA repairSkin cancer in solid organ transplant recipients: are mTOR inhibitors a game changer?Burden of de novo malignancy in the liver transplant recipientIncidence, risk factors and outcome of de novo tumors in liver transplant recipients focusing on alcoholic cirrhosisMelanoma Risk and Survival among Organ Transplant Recipients.Overexpression of selenoprotein H reduces Ht22 neuronal cell death after UVB irradiation by preventing superoxide formation.Thiopurines and inflammatory bowel disease: Current evidence and a historical perspectiveHarmful effects of the azathioprine metabolite 6-mercaptopurine in vascular cells: induction of mineralizationMore epidermal p53 patches adjacent to skin carcinomas in renal transplant recipients than in immunocompetent patients: the role of azathioprine.Visible light regulates neurite outgrowth of nerve cells.Whole-Exome Sequencing Validates a Preclinical Mouse Model for the Prevention and Treatment of Cutaneous Squamous Cell Carcinoma.Use of thiopurines in inflammatory bowel disease: Safety issues.Increased risk for non-melanoma skin cancer in patients with inflammatory bowel diseaseRisk of melanoma and nonmelanoma skin cancer among patients with inflammatory bowel diseaseCrosslinking of DNA repair and replication proteins to DNA in cells treated with 6-thioguanine and UVALC-MS/MS coupled with stable isotope dilution method for the quantification of 6-thioguanine and S(6)-methylthioguanine in genomic DNA of human cancer cells treated with 6-thioguaninePharmacogenetics of azathioprine in inflammatory bowel disease: a role for glutathione-S-transferase?Cancer Recurrence Following Immune-Suppressive Therapies in Patients With Immune-Mediated Diseases: A Systematic Review and Meta-analysis.Molecular profiling of cutaneous squamous cell carcinomas and actinic keratoses from organ transplant recipients.Overall and cause-specific mortality in Crohn's disease: a meta-analysis of population-based studies.Pathogenesis of nonmelanoma skin cancers in organ transplant recipientsThiopurines in current medical practice: molecular mechanisms and contributions to therapy-related cancer.Direct observation and quantitative characterization of singlet oxygen in aqueous solution upon UVA excitation of 6-thioguanines.Human skin carcinoma arising from kidney transplant-derived tumor cells.Nonmelanoma skin cancer in inflammatory bowel disease: a reviewProcarcinogenic effects of cyclosporine A are mediated through the activation of TAK1/TAB1 signaling pathwayRisk of merkel cell carcinoma after solid organ transplantation.Cyclosporine a mediates pathogenesis of aggressive cutaneous squamous cell carcinoma by augmenting epithelial-mesenchymal transition: role of TGFβ signaling pathway.Immune profiling and cancer post transplantationGeneration of reactive oxygen species by lethal attacks from competing microbes.Oral azathioprine leads to higher incorporation of 6-thioguanine in DNA of skin than liver: the protective role of the Keap1/Nrf2/ARE pathway.Roles of the immune system in skin cancer.Quantification of Thiopurine/UVA-Induced Singlet Oxygen Production
P2860
Q21261410-B7908D2D-A76E-439F-AD25-6BC8F2B87194Q26744266-B48E1EF2-AB07-4987-83ED-C9EE5C45E76CQ26745456-E170D9D0-DD9A-47F7-ABE3-B12EEA27C219Q26748580-5165AC0C-0126-44CC-8C4F-820943C9173FQ26750190-96E796C8-EB93-4DCE-844A-FF8F22A326A8Q26765172-70BC3F00-57B1-419A-AB86-9C8989B9B492Q26822029-D2BC29A1-E943-4233-BABC-E258EC0ACDB8Q26822549-D7D4634B-CBDD-464E-BD6A-6F134146170FQ26851436-1019F863-1E14-4209-A006-6DCD04E60272Q26859216-3038C22A-1E73-4072-8327-581912C0D979Q27025406-46E6C5D0-412B-428B-9486-5389101BEA9DQ27320787-246E74D9-8FF0-41AD-B5E3-14261231D4EBQ27863353-DEB7AEA4-2E3C-4031-B4E3-416AF52C9F6EQ28079644-F97E85F2-5781-46B2-BACA-9565B4BE85FBQ28540791-35A7EE53-53BB-4576-BC4B-601707E5A974Q30835452-E2DC50F0-99C9-418F-A1D0-EA368A84B455Q33383930-204C2F41-46E7-4C56-A282-43FC9EA28CC4Q33614146-5FE48B56-DF13-477D-9E0F-69443D50EC62Q33621267-AC9C7C6F-B297-4C88-9031-A5FB4CD61CB3Q33727211-CA64364F-3AAF-4842-93BD-CDDBD35C67FDQ33786255-240F1EDB-9F03-4856-9614-2CB37F94F9E2Q33844623-8FC413EA-A713-4678-98F3-94B8CE727083Q34070112-17F673FA-869F-401A-BACF-C6D34EFF6159Q34413976-E612D8E4-6B6F-4333-B80E-790E05EB3287Q34520662-579B3994-E657-404C-BC01-79F1938385CCQ34573854-01FDF018-A3AF-420A-8DBB-72892BFBFDE8Q34609514-DE92609E-ACE4-4373-9B44-309F02A3CEE7Q34713840-62F65317-3468-4648-ACFE-B8917302D618Q34728470-8E030AFD-626C-4D67-B054-55C3D0B0A963Q34815465-06590FA5-11FE-43BC-BBCC-591EAFA7791CQ34974648-9C0C63D4-977E-45E7-B9A1-321C14AC8CDDQ34975612-25896388-B198-49E5-A18E-8E7AF4DCF02CQ34984571-E19FB7B2-5322-4643-B302-1E832AAF4D78Q35029320-65F85A01-EB4A-421F-A3C0-91E22241D0D7Q35032846-05113B93-26E9-4D56-8B6F-6FD5AEEE9449Q35050810-52456578-AD6F-40AD-97ED-BE171549BB37Q35128847-75D3ADED-CDFB-4EE0-9D11-D4683CFF6916Q35283173-3FC8C20B-4086-47C9-8D01-E3EEF89C7A8AQ35403714-5A5969DD-CBD8-4150-8CB1-58364B3B4041Q35534821-505B324F-7D00-4674-9E5A-EA28283110F4
P2860
Azathioprine and UVA light generate mutagenic oxidative DNA damage
description
2005 nî lūn-bûn
@nan
2005 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Azathioprine and UVA light generate mutagenic oxidative DNA damage
@ast
Azathioprine and UVA light generate mutagenic oxidative DNA damage
@en
Azathioprine and UVA light generate mutagenic oxidative DNA damage
@nl
type
label
Azathioprine and UVA light generate mutagenic oxidative DNA damage
@ast
Azathioprine and UVA light generate mutagenic oxidative DNA damage
@en
Azathioprine and UVA light generate mutagenic oxidative DNA damage
@nl
prefLabel
Azathioprine and UVA light generate mutagenic oxidative DNA damage
@ast
Azathioprine and UVA light generate mutagenic oxidative DNA damage
@en
Azathioprine and UVA light generate mutagenic oxidative DNA damage
@nl
P2093
P2860
P50
P3181
P356
P1433
P1476
Azathioprine and UVA light generate mutagenic oxidative DNA damage
@en
P2093
Conal M Perrett
Fumio Hanaoka
Jane M McGregor
Peter Karran
Peter O'Donovan
Susan L Walker
Xiaohong Zhang
P2860
P304
P3181
P356
10.1126/SCIENCE.1114233
P407
P577
2005-09-16T00:00:00Z